Pink & pearl campaign aims to boost lung cancer screening in women

NCT ID NCT06898333

Recruiting now Knowledge-focused Sponsor: Washington University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 2 times

Summary

This study looks at whether a campaign called Pink & Pearl can increase lung cancer screening among women who are already getting mammograms. Researchers will track how many eligible women get screened and what factors help or hinder the process. About 279 women aged 50-80 with a history of smoking will take part. The goal is to find better ways to combine cancer screening programs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could show that combining breast and lung cancer screening programs improves early detection of lung cancer in women.
What could go wrong: This is an observational study, not a treatment trial. It measures screening uptake, not health outcomes. Results may not apply to other settings or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER OF THE LUNG are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung carcinoma lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER OF THE LUNG LUNG CANCER

Contacts and locations

Locations

Barnes-Jewish Hospital West County
RECRUITING

Creve Coeur, Missouri, 63141, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.